Get started
Author

Thomas E. White

ORCID: 0009-0002-9405-6621
Observed ORCID: 0009-0002-9405-6621
OpenAlex ID: A5122440054
Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al. · Molecular Cancer Therapeutics · 2
PDF
Supplementary Figure S1 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Table S3 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Table S1 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Table S2 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Figure S2 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Figure S3 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Supplementary Figure S4 from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Data from Development of Antibody–Drug Conjugates Targeting L1CAM to Treat Metastatic Cancer
2026 · Jin Suk Park, Carson Kenum, et al.
Works count: 9
Citation count: 2
H-index: 1
I10-index:
Year
Topic
Type